日水製薬(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証PRM | 医薬品 | 4550/E00971 | Nissui Pharmaceutical Co., Ltd |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2012/11/22 | 日証協 | 3,500株 | 0% | 2,946株 | +29.1% | 49,247株 | -1.79% | 200株 | -81.82% |
| 2012/11/16 | 日証協 | 3,500株 | +17.37% | 2,282株 | -3.47% | 50,147株 | -12.37% | 1,100株 | -83.08% |
| 2012/11/09 | 日証協 | 2,982株 | -11.83% | 2,364株 | -22.85% | 57,229株 | +8.33% | 6,500株 | +22.64% |
| 2012/11/02 | 日証協 | 3,382株 | -8.15% | 3,064株 | 0% | 52,829株 | +3.53% | 5,300株 | +1225% |
| 2012/10/26 | 日証協 | 3,682株 | -15.97% | 0株 | -100% | 51,029株 | -2.86% | 400株 | -88.57% |
| 2012/10/19 | 日証協 | 4,382株 | -13.77% | 3,082株 | -6.09% | 52,531株 | +0.19% | 3,500株 | +16.67% |
| 2012/10/12 | 日証協 | 5,082株 | -1.93% | 3,282株 | -57.63% | 52,431株 | +3.76% | 3,000株 | -58.39% |
| 2012/10/05 | 日証協 | 5,182株 | +33.49% | 7,746株 | +30.67% | 50,531株 | +40.71% | 7,209株 | -50.6% |
| 2012/09/28 | 日証協 | 3,882株 | -39.77% | 5,928株 | +30.43% | 35,912株 | -38.18% | 14,593株 | +838.46% |
| 2012/09/21 | 日証協 | 6,445株 | -44.91% | 4,545株 | +22.84% | 58,093株 | -4.53% | 1,555株 | -82.72% |
| 2012/09/14 | 日証協 | 11,700株 | +40.96% | 3,700株 | +362.5% | 60,848株 | +4.11% | 9,000株 | -39.6% |
| 2012/09/07 | 日証協 | 8,300株 | +5.06% | 800株 | +166.67% | 58,448株 | +3.73% | 14,900株 | +115.47% |
| 2012/08/31 | 日証協 | 7,900株 | +2.6% | 300株 | -92.86% | 56,348株 | +0.2% | 6,915株 | +332.19% |
| 2012/08/24 | 日証協 | 7,700株 | -10.47% | 4,200株 | 0% | 56,233株 | -4.26% | 1,600株 | -27.27% |
| 2012/08/17 | 日証協 | 8,600株 | -5.49% | 0株 | -100% | 58,733株 | +8.9% | 2,200株 | -79.25% |
| 2012/08/10 | 日証協 | 9,100株 | +8.33% | 1,100株 | -8.33% | 53,933株 | -3.92% | 10,600株 | +35.9% |
| 2012/08/03 | 日証協 | 8,400株 | +13.51% | 1,200株 | +140% | 56,133株 | +0.18% | 7,800株 | +11.43% |
| 2012/07/27 | 日証協 | 7,400株 | +2.78% | 500株 | 0% | 56,033株 | -1.41% | 7,000株 | +180% |
| 2012/07/20 | 日証協 | 7,200株 | -2.7% | 0株 | -100% | 56,833株 | -0.35% | 2,500株 | -47.92% |
※株式分割は考慮していませんのでご注意ください。